Cardiovascular complications of oral contraceptives

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular complications of oral contraceptives

Abstract

Citations

Targeting drugs to the brain by redox chemical delivery systems

Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases

Plasma and erythrocyte membrane fatty acids in oral contraceptive users

Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats

Ethynylestradiol alters lipid composition and phosphatidylethanolamine metabolism in red blood cells

Temporal changes in brain and organ contents of norepinephrine in estrogen-treated rats after 6-hydroxydopamine

Age and dosage differences in response of genetically hypertensive and normotensive rats to estrogen treatment

Age differences in blood pressure and norepinephrine concentration in normotensive rats after higher doses of estrogen

Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular risk

New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox

Venous thrombosis and rifampicin

Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems

Postmenopausal estrogen therapy and cardiovascular disease.

The influence of 17-beta-oestradiol and the natural oestrous cycle on alpha-adrenoceptor-mediated responses of the cardiovascular system in the rat

Effects of chronic intake of diazinon on blood and brain monoamines and amino acids.

Mild unilateral proteinuria and renal vein thrombosis associated with oral contraceptive usage

Superficial thrombophlebitis. II. Secondary hypercoagulable states

Blood pressure changes and hormonal contraceptives

Idiopathic ovarian vein thrombosis: a rare cause of abdominal pain

The role of the sympathetic nervous system in oestrogen-induced hypertension in rats

Effects of a brain-enhanced estrogen delivery system on tail-skin temperature of the rat: implications for menopausal hot flush

Drug targeting by retrometabolic design: soft drugs and chemical delivery systems

Apolipoprotein B of avian very low density lipoprotein: characteristics of its regulation in nonstimulated and estrogen-stimulated rooster

Coexistence of cerebral venous sinus and internal carotid artery thrombosis associated with exogenous sex hormones. A case report

Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity

Blood pressure and oral progestational agents. A prospective study of 119 black women

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Related Papers

Circadian changes in norepinephrine turnover in rats following administration of estrogen

Effects of mestranol on blood pressure and norepinephrine in young normotensive and genetically hypertensive rats

Temporal changes in brain and organ contents of norepinephrine in estrogen-treated rats after 6-hydroxydopamine

Synthesis of brain-targeted 1-(2-deoxy-2-fluoro-beta-D-ribofuranosyl)-(E)-5-(2-iodovinyl)uracil coupled to a dihydropyridine <---> pyridinium salt redox chemical-delivery system

Concentration of diazinon in air of a retail garden store